CLYM
Climb Bio, Inc.
Last earnings -2.5% on 2026-05-07
$12.75
▲ +3.66%$12.75▲ +936.59%
over 1Y
L $1.18EODHDH $12.75
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.7%
1W+12.4%
1M+11.9%
3M+82.7%
YTD+240.0%
1Y+936.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.05x).
Climb Bio, Inc. shows limited reported revenue, and -37.3% ROE.
Sources: SEC EDGAR (CIK 0001768446, latest 10-Q filed 2026-05-07) · EODHD · as of 6/25/2026, 3:43:41 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.